Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Breast Neoplasms 4Pain, Postoperative 2Vesico-Ureteral Reflux 1Uterine Neoplasms 1Ureteral Neoplasms 1Peritoneal Cancer 1Pancreatic Neoplasms 1Pain 1Ovarian Neoplasms 1Neuralgia 1Nephrolithiasis 1Neoplasms 1Malignant Neoplasms of Female Genital Organs 1Lung Neoplasms 1Leiomyoma 1Kidney Neoplasms 1Endometrial Neoplasms 1Endometrial Hyperplasia 1Digestive System Diseases 1Breast Cancer Female 1Abdominal Cancer 1

Interventions

Paclitaxel 25Doxorubicin 15Carboplatin 14pembrolizumab 10Cisplatin 8Radiotherapy 6Docetaxel 5Chemotherapy, Adjuvant 5Taxes 4Filgrastim 4Brachytherapy 4lenvatinib 3Observation 3trastuzumab deruxtecan 2selinexor 2olaparib 2durvalumab 2Tamoxifen 2Specimen Handling 2Ifosfamide 2Drug Therapy 2sintilimab 1sacituzumab govitecan 1pertuzumab 1nanocis 1liposomal doxorubicin 1ixabepilone 1gallium-diethylenetriaminepentaacetic acid-mannosyl-dextran 1dostarlimab 1atezolizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Endometrial Neoplasms × Bupivacaine × Clear all
NCT05763667 2025-04-24

Pilot: Intraoperative TAP Block and Post-operative Pain Control for Minimally Invasive Hysterectomy for Endometrial Cancer

Tufts Medical Center

Phase 3 Completed
15 enrolled
Gynecologic

Endometrial Hyperplasia, Pain, Postoperative, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡